Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.
Song-Yang ZhangMing-Jiang XuXian WangPublished in: British journal of pharmacology (2017)
This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.